HomeInsightsStock Comparison

Themis Medicare Ltd vs Zenlabs Ethica Ltd Stock Comparison

Themis Medicare Ltd vs Zenlabs Ethica Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Themis Medicare Ltd is ₹ 99.75 as of 18 Dec 15:30.
  • The P/E Ratio of Themis Medicare Ltd changed from 8.9 on March 2020 to 45.3 on March 2025 . This represents a CAGR of 31.15% over 6 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Themis Medicare Ltd changed from ₹ 220.51 crore on March 2020 to ₹ 1349 crore on March 2025 . This represents a CAGR of 35.25% over 6 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Themis Medicare Ltd for the Sep '25 is ₹ 82.97 crore as compare to the Jun '25 revenue of ₹ 98.75 crore. This represent the decline of -15.98% The revenue of Zenlabs Ethica Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Themis Medicare Ltd for the Sep '25 is ₹ 1.89 crore as compare to the Jun '25 ebitda of ₹ -9.04 crore. This represent the decline of -120% The ebitda of Zenlabs Ethica Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Themis Medicare Ltd changed from ₹ 18.19 crore to ₹ -3.62 crore over 10 quarters. This represents a CAGR of NaN% The net profit of Zenlabs Ethica Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Themis Medicare Ltd changed from 10.11 % on March 2020 to 19.23 % on March 2025 . This represents a CAGR of 11.31% over 6 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Themis Medicare Ltd

  • Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969.
  • The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993.
  • Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001.
  • The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.

About Zenlabs Ethica Ltd

  • Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
  • The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
  • It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
  • The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
  • Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

Themis Medicare Ltd News Hub

News

Themis Medicare to conduct board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

05 Nov 2025 14:09

News

Themis Medicare Ltd leads gainers in 'B' group

Consolidated Construction Consortium Ltd, Sigachi Industries Ltd, Lambodhara Textiles Ltd ...

Read more

12 Sep 2025 12:15

News

Themis Medicare to conduct AGM

Themis Medicare announced that the Annual General Meeting(AGM) of the company will be held...

Read more

21 Aug 2025 10:07

News

Themis Medicare schedules board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 1 August 2...

Read more

26 Jul 2025 10:34

News

Board of Themis Medicare recommends final dividend

Themis Medicare announced that the Board of Directors of the Company at its meeting held o...

Read more

21 May 2025 11:37

News

Themis Medicare to declare Quarterly Results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 20 May 202...

Read more

16 May 2025 16:53

Zenlabs Ethica Ltd News Hub

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 8 November ...

Read more

03 Nov 2025 15:50

News

Zenlabs Ethica to conduct AGM

Zenlabs Ethica announced that the Annual General Meeting(AGM) of the company will be held ...

Read more

12 Sep 2025 11:15

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 8 August 20...

Read more

02 Aug 2025 17:14

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

08 May 2025 11:05

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

07 May 2025 11:07

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February ...

Read more

31 Jan 2025 15:48

SWOT Analysis Of Zenlabs Ethica Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Themis Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Zenlabs Ethica Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Themis Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Themis Medicare Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Themis Medicare Ltd or Zenlabs Ethica Ltd?

Market cap of Themis Medicare Ltd is 932 Cr while Market cap of Zenlabs Ethica Ltd is 14 Cr

What are the key factors driving the stock performance of Themis Medicare Ltd and Zenlabs Ethica Ltd?

The stock performance of Themis Medicare Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Themis Medicare Ltd and Zenlabs Ethica Ltd?

As of December 18, 2025, the Themis Medicare Ltd stock price is INR ₹101.3. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹21.79.

How do dividend payouts of Themis Medicare Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Themis Medicare Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions